Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Eur Rev Med Pharmacol Sci ; 18(17): 2496-9, 2014.
Article de Anglais | MEDLINE | ID: mdl-25268095

RÉSUMÉ

Three young patients with Bickerstaff's brainstem encephalitis (BBE) are reported. Some weeks following an upper tract infection, the children after a short period of recovery, showed acute onset of symmetric weakness of the lower limbs with difficulty in standing by and walking. The distal muscle weakness had a rapid progression with involvement of the cranial nerve, and then with severe impairment of the consciousness till to coma in one of the three children. BBE is a rare and often underdiagnosed affection in childhood. Common neuro-immune pathogenesis, overlap of clinical signs and strict correlation among BBE with Fisher syndrome and Guillain-Barrè syndrome lead to think that these affections represent an unique spectrum with different central and peripheral involvement. In these children, treatment with intravenous immunoglobulins resulted in a progressive and rapid resolution of the clinical features.


Sujet(s)
Tronc cérébral/anatomopathologie , Encéphalite/traitement médicamenteux , Immunoglobulines par voie veineuse/usage thérapeutique , Tronc cérébral/effets des médicaments et des substances chimiques , Enfant , Enfant d'âge préscolaire , Encéphalite/diagnostic , Encéphalite/anatomopathologie , Femelle , Humains , Nourrisson , Mâle , Crises épileptiques/étiologie
2.
Neuropediatrics ; 41(6): 246-55, 2010 Dec.
Article de Anglais | MEDLINE | ID: mdl-21445814

RÉSUMÉ

BACKGROUND: There are only a few series in the literature on acute disseminated encephalomyelitis (ADEM) in children. OBJECTIVES AND METHODS: the aims of this study were to perform (i) a prospective clinical/imaging study (1992-2009) on ADEM in children consecutively referred to our institution in Catania, Italy, and (ii) to undertake a systematic review and meta-analysis of published ADEM pediatric cohorts (>10 cases). RESULTS: We identified 17 patients with ADEM (incidence <10 years of age=1.1 per 100 000 person-years). 15 previously published cohorts were compared with our cohort: (i) systematically reviewed (750 cases); and (ii) meta-analyzed (492/750 cases). The 17 patients had the following characteristics: (a) male-to-female ratio, 1.4 (vs. 1.2-1.3 in previous cohorts); (b) mean age at presentation, 3.6 years (vs. 7.1 years in previous cohorts); (c) specific preceding triggering factor, 88% (vs. 69-79% in previous cohorts); (d) the most common initial signs were ataxia, seizures, headache, and thalamic syndrome; (e) brain imaging revealed >3 lesions in 100% (vs. 92% in previous cohorts); (f) the outcome was good in 94% (vs. 70-75% in previous cohorts); and (g) 12% relapsed once (vs. 18% in previous cohorts). CONCLUSIONS: ADEM is generally a benign condition that mosly affects boys more than girls and rarely recurs.


Sujet(s)
Encéphale/anatomopathologie , Encéphalomyélite aigüe disséminée/diagnostic , Hormones corticosurrénaliennes/usage thérapeutique , Âge de début , Encéphale/physiopathologie , Enfant , Électroencéphalographie , Encéphalomyélite aigüe disséminée/traitement médicamenteux , Encéphalomyélite aigüe disséminée/physiopathologie , Femelle , Glucocorticoïdes/usage thérapeutique , Humains , Mâle , Pronostic , Études prospectives , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...